This webinar covered:
- What is health technology assessment (HTA)?
- What is the HTA Policy and Methods Review (HTA Review) and why is it being done?
- How can consumers get involved in the HTA Review?
- The information, evidence and input the HTA Policy and Methods Review Reference Committee are seeking from consumers
- The enhanced consumer engagement process and an update on work already underway
- HTA and rare disease therapies
- Key messages aligned with the National Strategic Action Plan for Rare Diseases